Home/Filings/4/0001193125-26-012080
4//SEC Filing

Treace John T. 4

Accession 0001193125-26-012080

CIK 0001630627other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 9:30 PM ET

Size

7.9 KB

Accession

0001193125-26-012080

Insider Transaction Report

Form 4
Period: 2026-01-10
Treace John T.
DirectorChief Executive Officer10% Owner
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-01-1013,2196,775,887 total
Holdings
  • Common Stock

    [F2]
    (indirect: By Spouse)
    1,605,000
  • Common Stock

    [F2]
    (indirect: By Trust)
    1,471,250
  • Common Stock

    [F3]
    (indirect: By Trust)
    1,839,063
  • Common Stock

    [F3]
    (indirect: By Trust)
    408,816
Footnotes (3)
  • [F1]Includes 363,867 restricted stock units.
  • [F2]The Reporting Person disclaims beneficial ownershup of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  • [F3]The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Signature
/s/ Lisa Taylor as Attorney-in-fact for John Treace|2026-01-13

Documents

1 file

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001856380

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 9:30 PM ET
Size
7.9 KB